COURPENDY
LIVE

Serial Number

99213557

Owner

H. Lundbeck A/S

Attorney

Maren Perry

Filing Date

Jun 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

COURPENDY Trademark

Serial Number: 99213557

COURPENDY is a trademark filed by H. Lundbeck A/S on June 2, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

June 2, 2025

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Medical apparatus, namely, infusion and injection devices for administering drugs; medical syringes, intravenous bags sold empty for intravenous therapy, intravenous (IV) feeding tubes, intravenous (IV) infusion pumps, and intravenous (IV) catheters; injection devices for administering drugs, medical syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines also containing downloadable and recorded software for medical information management for use in web-based physical and psychological examination and assessment of patients at a distance and at a clinic; medical devices and instruments for the diagnosis, administration, monitoring, assessment, control and examination of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune disorders and diseases; integrated medical systems for use with downloadable computer software comprised of medical instruments and recorded software sold in connection therewith for information and information management for use of a web-based physical and psychological and neurological examination and assessment of patients and clients; integrated medical systems comprised of medical devices and instruments for treating central nervous system diseases and disorders and psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune disorders and diseases, all for the purposes of management, measurement, monitoring, evaluation, control, collection, storage, transmission and examination of patient and client data and information; medical instruments for providing medication administering information, guidance, management in the nature of devices for delivery and administering of medicines and infusion pumps

Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the diagnosis, prevention and treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, rapid eye movement (REM) sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, sclerosis, multiple sclerosis, schizophrenia, bipolar disorder, cancer, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood disorders, falls, movement disorders and diseases, tremor, agitation, mania, aggression, autism, melancholia, Obsessive Compulsive Disorder (OCD), Tourette's syndrome, restlessness, akathisia, fatigue, somnolence, nausea, Cushing's disease, Adrenogenital syndrome (AGS), narcolepsy, Post-Traumatic Stress Disorder (PTSD), Attention Deficit Hyperactivity Disorder (ADHD), Progressive Supranuclear Palsy (PSP), Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and addiction; diagnostic agents and preparations for medical purposes; chemical substances for diagnostic and medical purposes, namely, chemical reagents for medical use, diagnostic chemical reagents for medical purposes; medical diagnostic reagents

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 2, 2026 GNFN
FINAL REFUSAL E-MAILED
Jan 2, 2026 GNFR
FINAL REFUSAL WRITTEN
Jan 2, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 15, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 2, 2025 MAFR
NEW APPLICATION ENTERED
Jun 2, 2025 NWAP